Utama › Limfoma Burkitt › Colorado › Aurora

Kajian klinikal Limfoma Burkitt di Aurora, CO

10 kajian untuk Limfoma Burkitt sedang mencari peserta di lokasi dalam dan sekitar Aurora (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Mengambil pesertaFasa 2

Children's Hospital Colorado, Aurora

366 Days – 46 Years · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06124157

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Mengambil pesertaKajian pemerhatian

Children's Hospital Colorado, Aurora

Umur 0 hingga 38 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Mengambil pesertaFasa 2

Children's Hospital Colorado, Aurora

365 Days · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora

6 Months – 25 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06395103

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Mengambil pesertaFasa 1/2

Children's Hospital Colorado, Aurora

31 Days – 30 Years · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04544592

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Mengambil pesertaFasa 2

Children's Hospital Colorado, Aurora

Umur 1 hingga 30 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Mengambil pesertaFasa 3

Children's Hospital Colorado, Aurora

365 Days – 25 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03959085

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Mengambil pesertaFasa 1

Children's Hospital Colorado, Aurora

3 Months – 30 Years · Semua jantina · Dikemas kini 28 Nov 2025 · NCT06559189

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Mengambil pesertaFasa 1/2

University of Colorado - Aurora Cancer Center, Aurora

Umur 15 hingga 50 · Semua jantina · Dikemas kini 9 Sep 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Mengambil pesertaFasa 2

Children's Hospital Colorado, Aurora

Umur 1 hingga 25 · Semua jantina · Dikemas kini 4 Mei 2025 · NCT03509961

Kajian Limfoma Burkitt di bandar lain

Kajian lain di Aurora

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.